Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2–Radiological features and metric markers
C Le Fevre, JM Constans, I Chambrelant… - Critical reviews in …, 2021 - Elsevier
After chemoradiotherapy for glioblastoma, pseudoprogression can occur and must be
distinguished from true progression to correctly manage glioblastoma treatment and follow …
distinguished from true progression to correctly manage glioblastoma treatment and follow …
[HTML][HTML] Diagnostic accuracy of PET for differentiating true glioma progression from post treatment-related changes: a systematic review and meta-analysis
M Cui, RI Zorrilla-Veloz, J Hu, B Guan, X Ma - Frontiers in Neurology, 2021 - frontiersin.org
Purpose: To evaluate the diagnostic accuracy of PET with different radiotracers and
parameters in differentiating between true glioma progression (TPR) and post treatment …
parameters in differentiating between true glioma progression (TPR) and post treatment …
Diagnosis of pseudoprogression following lomustine–temozolomide chemoradiation in newly diagnosed glioblastoma patients using FET-PET
JM Werner, J Weller, G Ceccon, C Schaub… - Clinical cancer …, 2021 - AACR
Abstract Purpose: The CeTeG/NOA-09 phase III trial demonstrated a significant survival
benefit of lomustine–temozolomide chemoradiation in patients with newly diagnosed …
benefit of lomustine–temozolomide chemoradiation in patients with newly diagnosed …
Brain FET PET tumor‐to‐white mater ratio to differentiate recurrence from post‐treatment changes in high‐grade gliomas
AD Puranik, V Rangarajan, ID Dev, Y Jain… - Journal of …, 2021 - Wiley Online Library
ABSTRACT Background and Purpose Highergrade glial neoplasms undergo standard
treatment with surgery, radiotherapy, and alkylating agents. There is often a …
treatment with surgery, radiotherapy, and alkylating agents. There is often a …
[PDF][PDF] 脑胶质瘤治疗后假性进展与复发的影像学鉴别研究进展
保莎莎， 刘一帆， 罗玥媛， 郭效宾， 李志林， 杨军… - 磁共振成像, 2021 - med-sci.cn
脑胶质瘤源自于神经上皮细胞, 是颅内最常见的原发性肿瘤, 其治疗方案为手术切除及后续的
同步放化疗, 但多达30% 的患者会出现新的磁共振成像内的强化病变, 这可能不是早期肿瘤进展 …
同步放化疗, 但多达30% 的患者会出现新的磁共振成像内的强化病变, 这可能不是早期肿瘤进展 …